Outcome analysis of pediatric hemophagocytic lymphohistiocytosis

被引:20
|
作者
Chen, Tsung-Yen [1 ,2 ]
Hsu, Mei-Hsin [1 ,3 ]
Kuo, Hsuan-Chang [1 ,4 ,5 ]
Sheen, Jiunn-Ming [6 ]
Cheng, Ming-Chou [1 ]
Lin, Ying-Jui [1 ,4 ]
机构
[1] Chang Gung Univ, Coll Med, Div Crit Care, Dept Pediat,Kaohsiung Chang Gung Mem Hosp, 123 Tapei Rd, Kaohsiung 333, Taiwan
[2] I Shou Univ, Dept Pediat, E Da Hosp, Kaohsiung, Taiwan
[3] Chang Gung Univ, Coll Med, Div Neurol, Dept Pediat,Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan
[4] Chang Gung Univ, Coll Med, Div Cardiol, Dept Pediat,Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan
[5] Meiho Univ, Dept Nursing, Neipu Township, Taiwan
[6] Chang Gung Univ, Coll Med, Div Hematol, Dept Pediat,Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan
关键词
Pediatric hemophagocytic syndrome; Hemophagocytic lympho histiocytosis; Macrophage activation syndrome; Mortality; Intensive care unit;
D O I
10.1016/j.jfma.2020.03.025
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disease associated with rapid clinical deterioration and the need for intensive care; therefore, it is essential to identify clinical parameters related to mortality and establish prognostic factors correlated with unfavorable outcome in high risk patients whose treatment may fail. Methods: Between January 2004 and December 2018, a total of 51 pediatric patients (less than 18 years old) who fulfilled the diagnostic criteria of HLH-2004 with documented results of bone marrow investigations at Kaohsiung Chang Gung Memorial Hospital were enrolled. The treatment protocol was based on hemophagocytic lymphohistiocytosis-94 (HLH-94) and HLH-2004. We retrospectively reviewed electronic medical records (EMR) including clinical features, length of intensive care unit (ICU) stay, serological tests, microscopic reports of bone marrow examination, and ultrasound examination reports at diagnosis to identify prognostic factors. The patients were divided into four groups based on etiology; these included infection associated hemophagocytic syndrome (IAHS), macrophage activation syndrome (MAS), malignancy associated hemophagocytic lymphohistiocytosis (MA-HLH), and idiopathic hemophagocytic lymphohistiocytosis (IHLH) to identify differences among the groups. Results: Out of 51 patients enrolled, 27 patients had IAHS, 12 MAS, 8 MA-HLH, and 4 IHLH. The median age at diagnosis was 7 years. The overall mortality rate was 15.7% (there was no mortality in the MA-HLH group); the mean length of ICU stay was 6 +/- 20.8 days. Longer activated partial thromboplastin time (aPTT) (p = 0.007), lower sodium concentration (p = 0.0007), and higher creatinine (p = 0.032) and aspartate aminotransferase (AST) (p = 0.017) were significantly related to mortality. Multivariate Cox regression analysis demonstrated that aPTT (p = 0.045, HR = 1.03, 95% CI = 1.0-1.1) was an independent risk factor for mortality. The receiver operating characteristic (ROC) curve showed that aPTT longer than 44.35 s was the cutoff value predicting mortality, with a sensitivity and specificity of 72% and 66.7%, respectively. Conclusion: MA-HLH had the lowest mortality rate, as most children died from the underlying malignant disease and not from HLH. Impaired liver and renal functions were related to mortality. Prolonged aPTT > 44.35 s is a strong predictive factor for mortality. Copyright (C) 2020, Formosan Medical Association. Published by Elsevier Taiwan LLC.
引用
收藏
页码:172 / 179
页数:8
相关论文
共 50 条
  • [21] Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis
    Chinn, Ivan K.
    Eckstein, Olive S.
    Peckham-Gregory, Erin C.
    Goldberg, Baruch R.
    Forbes, Lisa R.
    Nicholas, Sarah K.
    Mace, Emily M.
    Vogel, Tiphanie P.
    Abhyankar, Harshal A.
    Diaz, Maria I.
    Heslop, Helen E.
    Krance, Robert A.
    Martinez, Caridad A.
    Nguyen, Trung C.
    Bashir, Dalia A.
    Goldman, Jordana R.
    Stray-Pedersen, Asbjorg
    Pedroza, Luis A.
    Poli, M. Cecilia
    Aldave-Becerra, Juan C.
    McGhee, Sean A.
    Al-Herz, Waleed
    Chamdin, Aghiad
    Coban-Akdemir, Zeynep H.
    Jhangiani, Shalini N.
    Muzny, Donna M.
    Cao, Tram N.
    Hong, Diana N.
    Gibbs, Richard A.
    Lupski, James R.
    Orange, Jordan S.
    McClain, Kenneth L.
    Allen, Carl E.
    BLOOD, 2018, 132 (01) : 89 - 100
  • [22] THE BURDEN OF HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN PEDIATRIC CRITICAL CARE
    Nagarajan, Divya
    Williams, Cydni
    Orwoll, Ben
    Killien, Elizabeth
    Hartman, Mary
    CRITICAL CARE MEDICINE, 2024, 52
  • [23] Comparing hemophagocytic lymphohistiocytosis in pediatric and adult patients
    Wysocki, Christian A.
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 17 (06) : 405 - 413
  • [24] Pediatric CNS-isolated hemophagocytic lymphohistiocytosis
    Benson, Leslie A.
    Li, Hojun
    Henderson, Lauren A.
    Solomon, Isaac H.
    Soldatos, Ariane
    Murphy, Jennifer
    Bielekova, Bibiana
    Kennedy, Alyssa L.
    Rivkin, Michael J.
    Davies, Kimberly J.
    Hsu, Amy P.
    Holland, Steven M.
    Gahl, William A.
    Sundel, Robert P.
    Lehmann, Leslie E.
    Lee, Michelle A.
    Alexandrescu, Sanda
    Degar, Barbara A.
    Duncan, Christine N.
    Gorman, Mark P.
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2019, 6 (03):
  • [25] Hemophagocytic Lymphohistiocytosis in Children: Clinical Profile and Outcome
    Simon, Anna C.
    Kumar, Chinnaiah Govindhareddy Delhi
    Bast, Debdatta
    Kumar, Ramachandran Ramesh
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2020, 42 (05) : E281 - E285
  • [26] Neurological Manifestations Determine the Outcome of Hemophagocytic Lymphohistiocytosis
    Kim, Myung-Mi
    Yum, Mi-Sun
    Choi, Hae-Won
    Ko, Tae-Sung
    Im, Ho Joon
    Seo, Jong-Jin
    Koh, Kyung-Nam
    ANNALS OF NEUROLOGY, 2012, 72 : S182 - S182
  • [27] Possible roads to improve hemophagocytic lymphohistiocytosis outcome
    Merli, Pietro
    Jordan, Michael B.
    Locatelli, Franco
    BLOOD ADVANCES, 2020, 4 (24) : 6127 - 6129
  • [28] Familial hemophagocytic lymphohistiocytosis -: Primary hemophagocytic lymphohistiocytosis
    Henter, JI
    Aricò, M
    Elinder, G
    Imashuku, S
    Janka, G
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1998, 12 (02) : 417 - +
  • [29] The outcome of hematopoietic stem cell transplantation (HSCT) in pediatric patients with hemophagocytic lymphohistiocytosis (HLH) in Korea
    Park, Jun Eun
    Noh, O. Kyu
    Heo, Jaesung
    Park, Hyeon Jin
    Kim, Heri
    Seo, Jong Jin
    BONE MARROW TRANSPLANTATION, 2019, 54 : 389 - 390
  • [30] A Real-World Analysis of the Diagnostic Evaluation for Hemophagocytic Lymphohistiocytosis in a Pediatric Population
    Meyer, Lauren K.
    Steen, Erica A.
    Keenan, Camille
    Olshen, Adam B.
    Nichols, Kim E.
    Zinter, Matt S.
    BLOOD, 2023, 142